This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
See you next year! September 15-18, 2025
Hynes Convention CenterBoston, MA

Sarah Thomas
Senior Vice President, Quality at REGENXBIO Inc.
Speaker

Profile

Sarah Thomas is the Sr. Vice President of Quality at REGENXBIO, responsible for the Quality Assurance, Quality Control and Analytical Development organizations. She has over 30 years’ experience in pharmaceutical, biotech & gene therapy Quality. She has experience working with products at all phases of development, from early clinical phases to commercial distribution. She has led Quality teams through the transition from clinical to commercial operations, and through multiple product approvals. Ms. Thomas received an MBA from George Washington University and a BS in chemistry from Butler University.

Agenda Sessions

  • Chairperson's Remarks: Development of Emerging Cell & Gene Therapies

    11:10am
  • Phase-Appropriate Manufacturing: Trial and Error...or Trial and Triumph?

    2:30pm